Methods of treating mixed dyslipidemia and hypertriglycertdemia
AssigneeKowa Company, Ltd.
InventorsRyu Oshima, Kazuhito Suehira, Gary Gordon
Life of this patent
Estimating the term…
Abstract
The present invention relates to pharmacological interventions with pemafibrate for moderate or severe hypertriglyceridemia.
Claims15
A method of treating atherogenic dyslipidemia in a renally impaired dyslipidemic patient having an estimated glomerular filtration rate (eGFR) of less than 60 mL/min/1.73 m2 comprising administering to the patient 0.4 mg/day of pemafibrate or a pharmaceutically acceptable salt thereof in combination with moderate to high intensity statin therapy.
A method of treating atherogenic dyslipidemia in a renally impaired dyslipidemic patient having an estimated glomerular filtration rate (eGFR) of less than 60 mL/min/1.73 m2 comprising administering to the patient about 0.4 mg/day of pemafibrate or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.